Glucocorticoids trigger Alzheimer disease-like pathobiochemistry in rat neuronal cells expressing human tau

Journal of Neurochemistry

Volumn 107, Issue 2, 2008, Pages 385-397

  Sotiropoulos, Ioannis ^a,c   Catania, Caterina ^a,c   Riedemann, Therese ^a   Fry, Jonathan P ^c   Breen, Kieran C ^d   Michaelidis, Theologos M ^a,b   Almeida, Osborne F X ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b UNIVERSITY OF IOANNINA   (Greece)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Alzheimer's disease; Amyloid precursor protein; Glucocorticoids; PC12 cells; Rat neurons; Tau

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CYCLIN DEPENDENT KINASE 5; GLUCOCORTICOID; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; RAT;

AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CELL DIFFERENTIATION; CELL SURVIVAL; CYCLIN-DEPENDENT KINASE 5; CYCLIN-DEPENDENT KINASES; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; GREEN FLUORESCENT PROTEINS; HUMANS; NEURONS; PC12 CELLS; PHOSPHORYLATION; RATS; SIGNAL TRANSDUCTION; TAU PROTEINS; TETRAZOLIUM SALTS; THIAZOLES; TRANSFECTION;

RATTUS;

EID: 53149150976     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2008.05613.x     Document Type: Article

References (77)

1. Alonso A. C., Grundke-Iqbal I. Iqbal K. (1996) Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules. Nat. Med. 2, 783 787.
2. Alonso A. C., Li B., Grundke-Iqbal I. Iqbal K. (2006) Polymerization of hyperphosphorylated tau into filaments eliminates its inhibitory activity. Proc. Natl Acad. Sci. USA 103, 8864 8869.
3. Augustinack J. C., Schneider A., Mandelkow E. M. Hyman B. T. (2002) Specific tau phospho-rylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. Acta Neuropathol. (Berl) 103, 26 35.
4. Baki L., Shioi J., Wen P., Shao Z., Schwarzman A., Gama-Sosa M., Neve R. Robakis N. K. (2004) PS1 activates PI3K thus inhibiting GSK-3 activity and tau overphosphorylation: effects of FAD mutations. EMBO J. 23, 2586 2596.
5. Behl C., Lezoualch F., Trapp T., Widmann M., Skutella T. Holsboer F. (1997) Glucocorticoids enhance oxidative stress-induced cell death in hippocampal neurons in vitro. Endocrinology 138, 101 106.
6. Bennett E. J., Bence N. F., Jayakumar R. Kopito R. R. (2005) Global impairment of the ubiquitin-proteasome system by nuclear or cytoplasmic protein aggregates precedes inclusion body formation. Mol. Cell 17, 351 365.
7. Braak H., Braak E. Strothjohann M. (1994) Abnormally phosphorylated tau protein related to the formation of neurofibrillary tangles and neuropil threads in the cerebral cortex of sheep and goat. Neurosci. Lett. 171, 1 4.
8. Budas G., Coughlan C. M., Seckl J. R. Breen K. C. (1999) The effect of corticosteroids on amyloid beta precursor protein/amyloid precursor-like protein expression and processing in vivo. Neurosci. Lett. 276, 61 64.
9. Busciglio J., Lorenzo A., Yeh J. Yankner B. A. (1995) Beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron 14, 879 888.
10. Catania C., Sotiropoulos I., Silva R., Onofri C., Breen K. C., Sousa N. Almeida O. F. X. (2007) The amyloidogenic potential and behavioral correlates of stress. Mol. Psychiatry (in press).
11. Cerqueira J. J., Taipa R., Uylings H. B., Almeida O. F. X. Sousa N. (2007) Specific configuration of dendritic degeneration in pyramidal neurons of the medial prefrontal cortex induced by differing corticosteroid regimens. Cereb. Cortex 17, 1998 2006.
12. Chang K. A., Kim H. S., Ha T. Y. et al. (2006) Phosphorylation of amyloid precursor protein (APP) at Thr668 regulates the nuclear translocation of the APP intracellular domain and induces neurodegeneration. Mol. Cell. Biol. 26, 4327 4338.
13. Chun W. Johnson G. V. (2007) The role of tau phosphorylation and cleavage in neuronal cell death. Front. Biosci. 12, 733 756.
14. Crochemore C., Lu J., Wu Y., Liposits Z., Sousa N., Holsboer F. Almeida O. F. X. (2005) Direct targeting of hippocampal neurons for apoptosis by glucocorticoids is reversible by mineralocorticoid receptor activation. Mol. Psychiatry 10, 790 798.
15. Davis-Salinas J., Saporito-Irwin S. M., Cotman C. W. Van Nostrand W. E. (1995) Amyloid beta protein induces its own production in cultured degenerating cerebrovascular smooth muscle cells. J. Neurochem. 65, 931 934.
16. De Strooper B. (2005) Nicastrin: gatekeeper of the gamma-secretase complex. Cell 122, 318 320.
17. Elgh E., Lindqvist Astot A., Fagerlund M., Eriksson S., Olsson T. Nasman B. (2006) Cognitive dysfunction, hippocampal atrophy and glucocorticoid feedback in Alzheimer's disease. Biol. Psychiatry 59, 155 161.
18. Fath T., Eidenmuller J. Brandt R. (2002) Tau-mediated cytotoxicity in a pseudohyperphosphorylation model of Alzheimer's disease. J. Neurosci. 22, 9733 9741.
19. Geschwind D. H. (2003) Tau phosphorylation, tangles, and neurodegeneration: the chicken or the egg? Neuron 40, 457 460.
20. Geula C., Wu C. K., Saroff D., Lorenzo A., Yuan M. Yankner B. A. (1998) Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity. Nat. Med. 4, 827 831.
21. Goedert M., Spillantini M. G., Potier M. C., Ulrich J. Crowther R. A. (1989) Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. EMBO J. 8, 393 399.
22. Gotz J., Schild A., Hoerndli F. Pennanen L. (2004) Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease: insight from transgenic mouse and tissue-culture models. Int. J. Dev. Neurosci. 22, 453 465.
23. Green K. N., Billings L. M., Roozendaal B., McGaugh J. L. LaFerla F. M. (2006) Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer's disease. J. Neurosci. 26, 9047 9056.
24. Hampel H., Burger K., Pruessner J. C. et al. (2005) Correlation of cerebrospinal fluid levels of tau protein phosphorylated at threonine 231 with rates of hippocampal atrophy in Alzheimer disease. Arch. Neurol. 62, 770 773.
25. Hardy J. (2006) Has the amyloid cascade hypothesis for Alzheimer's disease been proved? Curr. Alzheimer Res. 3, 71 73.
26. Hartmann A., Veldhuis J. D., Deuschle M., Standhardt H. Heuser I. (1997) Twenty-four hour cortisol release profiles in patients with Alzheimer's and Parkinson's disease compared to normal controls: ultradian secretory pulsatility and diurnal variation. Neurobiol. Aging 18, 285 289.
27. Holzer M., Holzapfel H. P., Zedlick D., Bruckner M. K. Arendt T. (1994) Abnormally phosphorylated tau protein in Alzheimer's disease: heterogeneity of individual regional distribution and relationship to clinical severity. Neuroscience 63, 499 516.
28. Iijima K., Ando K., Takeda S., Satoh Y., Seki T., Itohara S., Greengard P., Kirino Y., Nairn A. C. Suzuki T. (2000) Neuron-specific phosphorylation of Alzheimer's beta-amyloid precursor protein by cyclin-dependent kinase 5. J. Neurochem. 75, 1085 1091.
29. Islam A., Kalaria R. N., Winblad B. Adem A. (1998) Enhanced localization of amyloid beta precursor protein in the rat hippocampus following long-term adrenalectomy. Brain Res. 806, 108 112.
30. Jeong Y. H., Park C. H., Yoo J., Shin K. Y., Ahn S. M., Kim H. S., Lee S. H., Emson P. C. Suh Y. H. (2006) Chronic stress accelerates learning and memory impairments and increases amyloid deposition in APPV717I-CT100 transgenic mice, an Alzheimer's disease model. FASEB J. 20, 729 731.
31. Johnson G. V. Stoothoff W. H. (2004) Tau phosphorylation in neuronal cell function and dysfunction. J. Cell Sci. 117, 5721 5729.
32. Jope R. S. Johnson G. V. (2004) The glamour and gloom of glycogen synthase kinase-3. Trends Biochem. Sci. 29, 95 102.
33. Keck S., Nitsch R., Grune T. Ullrich O. (2003) Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease. J. Neurochem. 85, 115 122.
34. Keller J. N., Hanni K. B. Markesbery W. R. (2000) Impaired proteasome function in Alzheimer's disease. J. Neurochem. 75, 436 439.
35. Kimura T., Ono T., Takamatsu J., Yamamoto H., Ikegami K., Kondo A., Hasegawa M., Ihara Y., Miyamoto E. Miyakawa T. (1996) Sequential changes of tau-site-specific phosphorylation during development of paired helical filaments. Dementia 7, 177 181.
36. Kirschenbaum F., Hsu S. C., Cordell B. McCarthy J. V. (2001a) Glycogen synthase kinase-3beta regulates presenilin 1 C-terminal fragment levels. J. Biol. Chem. 276, 30701 30707.
37. Kirschenbaum F., Hsu S. C., Cordell B. McCarthy J. V. (2001b) Substitution of a glycogen synthase kinase-3beta phosphorylation site in presenilin 1 separates presenilin function from beta-catenin signaling. J. Biol. Chem. 276, 7366 7375.
38. Le W. D., Xie W. J., Kong R. Appel S. H. (1997) Beta-amyloid-induced neurotoxicity of a hybrid septal cell line associated with increased tau phosphorylation and expression of beta-amyloid precursor protein. J. Neurochem. 69, 978 985.
39. Li Y., Zhou W., Tong Y., He G. Song W. (2006) Control of APP processing and Abeta generation level by BACE1 enzymatic activity and transcription. FASEB J. 20, 285 292.
40. Litersky J. M. Johnson G. V. (1992) Phosphorylation by cAMP-dependent protein kinase inhibits the degradation of tau by calpain. J. Biol. Chem. 267, 1563 1568.
41. Lorenzo A., Yuan M., Zhang Z., Paganetti P. A., Sturchler-Pierrat C., Staufenbiel M., Mautino J., Vigo F. S., Sommer B. Yankner B. A. (2000) Amyloid beta interacts with the amyloid precursor protein: a potential toxic mechanism in Alzheimer's disease. Nat. Neurosci. 3, 460 464.
42. Lu J., Goula D., Sousa N. Almeida O. F. X. (2003) Ionotropic and metabotropic glutamate receptor mediation of glucocorticoid-induced apoptosis in hippocampal cells and the neuroprotective role of synaptic N-methyl-D-aspartate receptors. Neuroscience 121, 123 131.
43. Lucas J. J., Hernandez F., Gomez-Ramos P., Moran M. A., Hen R. Avila J. (2001) Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice. EMBO J. 20, 27 39.
44. Mandelkow E. (1999) Alzheimer's disease. The tangled tale of tau. Nature 402, 588 589.
45. McGowan E., Eriksen J. Hutton M. (2006) A decade of modeling Alzheimer's disease in transgenic mice. Trends Genet. 22, 281 289.
46. Merrick S. E., Demoise D. C. Lee V. M. (1996) Site-specific dephosphorylation of tau protein at Ser202/Thr205 in response to microtubule depolymerization in cultured human neurons involves protein phosphatase 2A. J. Biol. Chem. 271, 5589 5594.
47. Miller T. P., Taylor J., Rogerson S., Mauricio M., Kennedy Q., Schatzberg A., Tinklenberg J. Yesavage J. (1998) Cognitive and noncognitive symptoms in dementia patients: relationship to cortisol and dehydroepiandrosterone. Int. Psychogeriatr. 10, 85 96.
48. Murray M. J., Merritt D. J., Brand A. H. Whitington P. M. (1998) In vivo dynamics of axon path-finding in the Drosophilia CNS: a time-lapse study of an identified motorneuron. J. Neurobiol. 37, 607 621.
49. Nalbantoglu J., Tirado-Santiago G., Lahsaini A. et al. (1997) Impaired learning and LTP in mice expressing the carboxy terminus of the Alzheimer amyloid precursor protein. Nature 387, 500 505.
50. Patrick G. N., Zukerberg L., Nikolic M., de la Monte S., Dikkes P. Tsai L. H. (1999) Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402, 615 622.
51. Phiel C. J., Wilson C. A., Lee V. M. Klein P. S. (2003) GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides. Nature 423, 435 439.
52. Poppek D., Keck S., Ermak G., Jung T., Stolzing A., Ullrich O., Davies K. J. Grune T. (2006) Phosphorylation inhibits turnover of the tau protein by the proteasome: influence of RCAN1 and oxidative stress. Biochem. J. 400, 511 520.
53. Rapoport M., Dawson H. N., Binder L. I., Vitek M. P. Ferreira A. (2002) Tau is essential to beta-amyloid-induced neurotoxicity. Proc. Natl Acad. Sci. USA 99, 6364 6369.
54. Reinhard C., Hebert S. S. De Strooper B. (2005) The amyloid-beta precursor protein: integrating structure with biological function. EMBO J. 24, 3996 4006.
55. Ren Q. G., Liao X. M., Chen X. Q., Liu G. P. Wang J. Z. (2007) Effects of tau phosphorylation on proteasome activity. FEBS Lett. 581, 1521 1528.
56. Roberson E. D., Scearce-Levie K., Palop J. J., Yan F., Cheng I. H., Wu T., Gerstein H., Yu G. Q. Mucke L. (2007) Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science 316, 750 754.
57. Rockenstein E., Torrance M., Adame A., Mante M., Bar-on P., Rose J. B., Crews L. Masliah E. (2007) Neuroprotective effects of regulators of the glycogen synthase kinase-3beta signaling pathway in a transgenic model of Alzheimer's disease are associated with reduced amyloid precursor protein phosphorylation. J. Neurosci. 27, 1981 1991.
58. Roselli F., Tirard M., Lu J., Hutzler P., Lamberti P., Livrea P., Morabito M. Almeida O. F. X. (2005) Soluble H-Amyloid1-40 induces NMDA-dependent degradation of postsynaptic density-95 at glutam-atergic synapses. J. Neurosci. 25, 11061 11070.
59. Sambamurti K., Kinsey R., Maloney B., Ge Y. W. Lahiri D. K. (2004) Gene structure and organization of the human beta-secretase (BACE) promoter. FASEB J. 18, 1034 1036.
60. Sapolsky R. M. (2000) The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death. Biol. Psychiatry 48, 755 765.
61. Sawamura N., Ko M., Yu W., Zou K., Hanada K., Suzuki T., Gong J. S., Yanagisawa K. Michikawa M. (2004) Modulation of amyloid precursor protein cleavage by cellular sphingolipids. J. Biol. Chem. 279, 11984 11991.
62. Shahani N. Brandt R. (2002) Functions and malfunctions of the tau proteins. Cell. Mol. Life Sci. 59, 1668 1680.
63. Shahani N., Subramaniam S., Wolf T., Tackenberg C. Brandt R. (2006) Tau aggregation and progressive neuronal degeneration in the absence of changes in spine density and morphology after targeted expression of Alzheimer's disease-relevant tau constructs in organotypic hippocampal slices. J. Neurosci. 26, 6103 6114.
64. Shulman J. M. Feany M. B. (2003) Genetic modifiers of tauopathy in Drosophila. Genetics 165, 1233 1242.
65. Smith M. A., Taneda S., Richey P. L. et al. (1994) Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc. Natl Acad. Sci. USA 91, 5710 5714.
66. Smith M. A., Siedlak S. L., Richey P. L. et al. (1995) Tau protein directly interacts with the amyloid beta-protein precursor: implications for Alzheimer's disease. Nat. Med. 1, 365 369.
67. Spillantini M. G. Goedert M. (1998) Tau protein pathology in neurodegenerative diseases. Trends Neurosci. 21, 428 433.
68. Steiner H., Capell A., Pesold B. et al. (1998) Expression of Alzheimer's disease-associated presenilin-1 is controlled by proteolytic degradation and complex formation. J. Biol. Chem. 273, 32322 32331.
69. Takashima A., Murayama M., Murayama O. et al. (1998) Presenilin 1 associates with glycogen synthase kinase-3beta and its substrate tau. Proc. Natl Acad. Sci. USA 95, 9637 9641.
70. Terry R. D. (1998) The cytoskeleton in Alzheimer disease. J. Neural Transm. Suppl. 53, 141 145.
71. Thinakaran G., Borchelt D. R., Lee M. K. et al. (1996) Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron 17, 181 190.
72. Wang J. Z., Grundke-Iqbal I. Iqbal K. (2007a) Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration. Eur. J. Neurosci. 25, 59 68.
73. Wang Y. P., Biernat J., Pickhardt M., Mandelkow E. Mandelkow E. M. (2007b) Stepwise proteolysis liberates tau fragments that nucleate the Alzheimer-like aggregation of full-length tau in a neuronal cell model. Proc. Natl Acad. Sci. USA 104, 10252 10257.
74. Weiner M. F., Vobach S., Olsson K., Svetlik D. Risser R. C. (1997) Cortisol secretion and Alzheimer's disease progression. Biol. Psychiatry 42, 1030 1038.
75. Wilson R. S., Barnes L. L., Bennett D. A., Li Y., Bienias J. L., Mendes de Leon C. F. Evans D. A. (2005) Proneness to psychological distress and risk of Alzheimer disease in a biracial community. Neurology 64, 380 382.
76. Yang A. J., Chandswangbhuvana D., Shu T., Henschen A. Glabe C. G. (1999) Intracellular accumulation of insoluble, newly synthesized abetan-42 in amyloid precursor protein transfected cells that have been treated with Abeta1-42. J. Biol. Chem. 274, 20650 20656.
77. Yankner B. A., Dawes L. R., Fisher S., Villa-Komaroff L., Oster-Granite M. L. Neve R. L. (1989) Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science 245, 417 420.